{"DataElement":{"publicId":"4163952","version":"1","preferredName":"Immunoglobulin Heavy Chain Serum Present Type","preferredDefinition":"A description of immunoglobulin heavy chain(s) present in the serum.","longName":"3029596v1.0:2951778v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3029596","version":"1","preferredName":"Immunoglobulin Heavy Chain Serum Present","preferredDefinition":"A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions._The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins._Being or existing in a specified place or at the specified time.","longName":"2950919v1.0:3029594v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2950919","version":"1","preferredName":"Immunoglobulin Heavy Chain","preferredDefinition":"A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions.","longName":"C16717","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoglobulin Heavy Chain","conceptCode":"C16717","definition":"A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"755FFAFB-6071-3800-E040-BB89AD43561E","latestVersionIndicator":"Yes","beginDate":"2009-10-07","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2009-10-07","modifiedBy":"ONEDATA","dateModified":"2009-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3029594","version":"1","preferredName":"Serum Present","preferredDefinition":"The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.:Being or existing in a specified place or at the specified time.","longName":"C13325:C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serum","conceptCode":"C13325","definition":"The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82918218-0155-2460-E040-BB89AD43750A","latestVersionIndicator":"Yes","beginDate":"2010-03-24","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-03-24","modifiedBy":"ONEDATA","dateModified":"2010-03-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"82918218-0166-2460-E040-BB89AD43750A","latestVersionIndicator":"Yes","beginDate":"2010-03-24","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-03-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2951778","version":"1","preferredName":"Immunoglobulin Heavy Chain Type","preferredDefinition":"A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions._Type; a subdivision of a particular kind of thing.","longName":"2951778v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IgM","valueDescription":"IgM","ValueMeaning":{"publicId":"2568587","version":"1","preferredName":"IgM","longName":"2568587","preferredDefinition":"The major immunoglobulin secreted during a primary immune response.  IgM binds with low affinity but high avidity (multiple binding sites) because it not only occurs as monomers but also as pentamers and hexamers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgM","conceptCode":"C569","definition":"The major immunoglobulin secreted during a primary immune response.  IgM binds with low affinity but high avidity (multiple binding sites) because it not only occurs as monomers but also as pentamers and hexamers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D8F8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-25","modifiedBy":"CHILLIJ","dateModified":"2007-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"7583F3A9-D66C-9901-E040-BB89AD432F65","beginDate":"2009-10-09","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2009-10-09","modifiedBy":"ONEDATA","dateModified":"2009-10-09","deletedIndicator":"No"},{"value":"IgG","valueDescription":"IgG","ValueMeaning":{"publicId":"2658037","version":"1","preferredName":"IgG","longName":"2658037","preferredDefinition":"An immunoglobulin isotype (subclass) that characterizes secondary immune responses.  This isotype is further broken down into several smaller subclasses (IgG1, IgG2a, IgG2b, IgG3 in the mouse; IgG1-4 in the human), and each subclass is differentially synthesized and secreted into the serum upon differential immune stimuli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgG","conceptCode":"C568","definition":"An immunoglobulin isotype (subclass) that characterizes secondary immune responses.  This isotype is further broken down into several smaller subclasses (IgG1, IgG2a, IgG2b, IgG3 in the mouse; IgG1-4 in the human), and each subclass is differentially synthesized and secreted into the serum upon differential immune stimuli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-90C0-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"7583F3A9-D676-9901-E040-BB89AD432F65","beginDate":"2009-10-09","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2009-10-09","modifiedBy":"ONEDATA","dateModified":"2009-10-09","deletedIndicator":"No"},{"value":"IgE","valueDescription":"IgE","ValueMeaning":{"publicId":"2658040","version":"1","preferredName":"IgE","longName":"2658040","preferredDefinition":"An immunoglobulin isotype (subclass).  This isotype has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast cells and basophils and induce degranulation and cytokine production by these cells when they are crosslinked by antigen.  In addition to a central role in atopy and allergic responses, it has been speculated that IgE-mediated mast cell degranulation, by its release of mediators that increase vascular permeability, has an important role in the initiation of immune response in general.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgE","conceptCode":"C567","definition":"An immunoglobulin isotype (subclass).  This isotype has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast cells and basophils and induce degranulation and cytokine production by these cells when they are crosslinked by antigen.  In addition to a central role in atopy and allergic responses, it has been speculated that IgE-mediated mast cell degranulation, by its release of mediators that increase vascular permeability, has an important role in the initiation of immune response in general.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-914C-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Updated Definition/Description to match NCIt.  Added text \"In addition to...  ...response in general.\" mcolbert 1/9/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"7583F3A9-D680-9901-E040-BB89AD432F65","beginDate":"2009-10-09","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2009-10-09","modifiedBy":"ONEDATA","dateModified":"2009-10-09","deletedIndicator":"No"},{"value":"IgD","valueDescription":"IgD","ValueMeaning":{"publicId":"2658039","version":"1","preferredName":"IgD","longName":"2658039","preferredDefinition":"An immunoglobulin isotype (subclass).  This isotype is expressed on naive B cells along with IgM.  Little is known about its physiologic role.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgD","conceptCode":"C566","definition":"An immunoglobulin isotype (subclass).  This isotype is expressed on naive B cells along with IgM.  Little is known about its physiologic role.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-9126-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"7583F3A9-D68A-9901-E040-BB89AD432F65","beginDate":"2009-10-09","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2009-10-09","modifiedBy":"ONEDATA","dateModified":"2009-10-09","deletedIndicator":"No"},{"value":"IgA","valueDescription":"IgA","ValueMeaning":{"publicId":"2658038","version":"1","preferredName":"IgA","longName":"2658038","preferredDefinition":"IgA is the immunoglobulin subclass that is associated with antibody-mediated mucosal immunity.  It is secreted as dimers into the mucosa and is the most effective isotype at fixing complement by the alternative pathway, even though it lacks the ability to fix complement by the classical pathway. There are two subtypes in the human - IgA1 and IgA2.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgA","conceptCode":"C565","definition":"IgA is the immunoglobulin subclass that is associated with antibody-mediated mucosal immunity.  It is secreted as dimers into the mucosa and is the most effective isotype at fixing complement by the alternative pathway, even though it lacks the ability to fix complement by the classical pathway. There are two subtypes in the human - IgA1 and IgA2.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-90E4-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"7583F3A9-D694-9901-E040-BB89AD432F65","beginDate":"2009-10-09","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2009-10-09","modifiedBy":"ONEDATA","dateModified":"2009-10-09","deletedIndicator":"No"},{"value":"Heavy chain present, type unknown","valueDescription":"Unknown Type Immunoglobulin Heavy Chain Present","ValueMeaning":{"publicId":"3182817","version":"1","preferredName":"Unknown Type Immunoglobulin Heavy Chain Present","longName":"3182817","preferredDefinition":"Not known, not observed, not recorded, or refused.: Type; a subdivision of a particular kind of thing.: A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions.: Being or existing in a specified place or at the specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunoglobulin Heavy Chain","conceptCode":"C16717","definition":"A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9997FC78-F375-66C2-E040-BB89AD4357EB","latestVersionIndicator":"Yes","beginDate":"2011-01-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-01-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9997FC78-F38E-66C2-E040-BB89AD4357EB","beginDate":"2011-01-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-01-11","modifiedBy":"ONEDATA","dateModified":"2011-01-11","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F26224D7-A79B-9F52-E040-BB89AD434864","beginDate":"2014-02-14","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-02-14","modifiedBy":"ONEDATA","dateModified":"2014-02-14","deletedIndicator":"No"},{"value":"Biclonal","valueDescription":"Biclonal Gammopathy","ValueMeaning":{"publicId":"4221295","version":"1","preferredName":"Biclonal Gammopathy","longName":"4221295","preferredDefinition":"A primary disturbance in immunoglobulin synthesis characterized by the presence of two distinct monoclonal immunoglobulins in the serum or urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biclonal Gammopathy","conceptCode":"C74936","definition":"A primary disturbance in immunoglobulin synthesis characterized by the presence of two distinct monoclonal immunoglobulins in the serum or urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F494B880-CB7E-130D-E040-BB89AD437019","latestVersionIndicator":"Yes","beginDate":"2014-03-14","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F494B880-CB96-130D-E040-BB89AD437019","beginDate":"2014-03-14","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-03-14","modifiedBy":"ONEDATA","dateModified":"2014-03-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2951777","version":"1","preferredName":"Immunoglobulin Heavy Chain Type","preferredDefinition":"A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions.:Type; a subdivision of a particular kind of thing.","longName":"C16717:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoglobulin Heavy Chain","conceptCode":"C16717","definition":"A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7583F3A9-D648-9901-E040-BB89AD432F65","latestVersionIndicator":"Yes","beginDate":"2009-10-09","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2009-10-09","modifiedBy":"ONEDATA","dateModified":"2009-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7583F3A9-D659-9901-E040-BB89AD432F65","latestVersionIndicator":"Yes","beginDate":"2009-10-09","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2009-10-09","modifiedBy":"COOPERM","dateModified":"2020-11-20","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"PCDpre_lab_diag_serum_heavy_chain_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What immunoglobulin heavy cha","type":"Preferred Question Text","description":"What immunoglobulin heavy chain was present in the serum?","url":null,"context":"NHLBI"},{"name":"Serum heavy chain","type":"Alternate Question Text","description":"Serum heavy chain","url":null,"context":"NHLBI"},{"name":"Serum heavy chain","type":"Application Standard Question Text","description":"Serum heavy chain","url":null,"context":"NHLBI"},{"name":"Specify serum heavy chain type(s) present","type":"Alternate Question Text","description":"Specify serum heavy chain type(s) present","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2D7BBC2-C8F2-23FF-E040-BB89AD432824","latestVersionIndicator":"Yes","beginDate":"2014-02-20","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-02-20","modifiedBy":"NYCHM","dateModified":"2017-04-04","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}